May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Assembly and Characterization of a Muscimol–Immobilized Silicon Surface
Author Affiliations & Notes
  • B.J. Nehilla
    Biomedical Engineering and Pharmacology, Chemistry,
    Boston University, Boston, MA
  • K.C. Popat
    Biomedical Engineering, Ophthalmology and Visual Sciences,
    Boston University, Boston, MA
  • S. Chowdhury
    Biomedical Engineering and Pharmacology, Chemistry,
    University of Illinois at Chicago, Chicago, IL
  • R.F. Standaert
    Biomedical Engineering and Pharmacology, Chemistry,
    University of Illinois at Chicago, Chicago, IL
  • D.R. Pepperberg
    Biomedical Engineering, Ophthalmology and Visual Sciences,
    University of Illinois at Chicago, Chicago, IL
  • T.A. Desai
    Biomedical Engineering, Ophthalmology and Visual Sciences,
    Boston University, Boston, MA
  • Footnotes
    Commercial Relationships  B.J. Nehilla, None; K.C. Popat, None; S. Chowdhury, None; R.F. Standaert, None; D.R. Pepperberg, None; T.A. Desai, None.
  • Footnotes
    Support  NIH grant EY13693 and Univ. of Illinois IRIB grant
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4194. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B.J. Nehilla, K.C. Popat, S. Chowdhury, R.F. Standaert, D.R. Pepperberg, T.A. Desai; Assembly and Characterization of a Muscimol–Immobilized Silicon Surface . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4194.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Efficient GABAergic neurotransmission is required for normal visual function in the retina. A severe consequence of certain retinal degenerative diseases is impaired neurotransmitter–mediated signaling from the photoreceptors to post–photoreceptor retinal neurons. An innovative approach to improve retinal function is the use of micro– or nanoscale devices to interact immobilized neurotransmitters or other active ligands with post–synaptic membrane receptors. As an expansion of initial work with GABA–analog surfaces (1), we have developed an immobilization strategy for muscimol, a potent GABA receptor agonist. Characterization data presented here show the results of surface modification steps and indicate successful muscimol immobilization on silicon wafers. Methods: Silicon surfaces were cleaned and hydroxylated before vapor–phase silanization in vacuum. The silanized surfaces were then incubated in a solution of avidin, EDAC and NHSS for avidin conjugation. Biotinylated muscimol was bound to the avidin–conjugated surfaces through avidin–biotin chemistry. Surfaces were analyzed with contact angle measurements and ellipsometry after each assembly step. Final surfaces were analyzed by X–ray photoelectron spectroscopy (XPS). Results: Ellipsometer data indicated height changes after each surface modification. Silanization, avidin conjugation and biotinylated muscimol immobilization increased surface heights by 20.5 +/– 3.47 Å, 14.2 +/– 2.09 Å and 12.3 +/– 2.51 Å, respectively. Contact angle measurements supported ellipsometry observations. The contact angles for the silanized, avidin–conjugated and biotinylated muscimol–immobilized surfaces were respectively 65 +/– 5.7°, 41.2 +/– 3.03° and 40.6 +/– 1.15°. XPS data further indicated successful muscimol immobilization by a C:N mass ratio increase compared to avidin–conjugated surfaces. Conclusions: The results indicate that the employed immobilization strategy based on avidin–biotin chemistry is effective for attaching muscimol to silicon surfaces. The data have inspired additional work to investigate the application of this technique to nanoscale surfaces and to integrate other neurotransmitter receptor effectors. (1) Vu et al., 2003 ARVO.

Keywords: neurotransmitters/neurotransmitter systems • synapse • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×